Papers

7

Total Citations

68

H-Index

4

About

Jeff Slezak’s research centers on improving patient outcomes in prostate cancer care, with a particular focus on health-related quality of life (HRQoL) and the real-world impact of surgical and behavioral interventions. His most cited work, a 2017 study drawing from a large, diverse population registry, tracked HRQoL up to 24 months post-treatment, providing critical benchmarks for patient counseling. Slezak also explored the intersection of lifestyle and recovery, demonstrating in a 2017 study that a smoking cessation program significantly improved sexual function recovery following robotic prostatectomy. His investigations extend to surgical training and decision-making, including the effects of trainee involvement and surgeon experience on treatment selection and proficiency. With over 70 citations across his key papers, Slezak’s contributions are particularly valued for their basis in large, integrated healthcare system data, offering pragmatic insights into the long-term consequences of prostate cancer therapy and the factors that shape recovery and healthcare utilization. His work helps bridge the gap between clinical trials and everyday practice.

Research Focus

Key Achievements

4
H-Index
7
Papers
68
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Health‐related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population
30 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Kaiser Permanente, Colorado Permanente Medical Group

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago